News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Business Standard Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Sturm, Ruger & Company, Inc. (NYSE:RGR) is in focus following a surge in searches related to a potential U.S. appeal of a National Firearms Act (NFA) ruling. A federal judge recently ruled that registration provisions for untaxed NFA items, including suppressors and short-barreled rifles, …
Sturm, Ruger & Company, Inc. (NYSE:RGR) is approaching its ex-dividend date on August 14th, meaning investors must purchase shares before then to receive the upcoming US$0.21 dividend per share, payable on August 28th. The company currently offers a 1.2% trailing yield and pays out …
Zacks Research has downgraded Sturm, Ruger & Company, Inc. (NYSE:RGR) to a "strong sell" rating, despite the company recently beating earnings estimates with $0.52 per share and a 19.3% increase in revenue year over year. The stock opened at $37.07, below its 50-day and …
Dimensional Fund Advisors LP increased its stake in Sturm, Ruger & Company, Inc. (RGR) by 7.3% in the first quarter, now owning 397,446 shares valued at $15.9 million. This comes as Sturm, Ruger reported strong quarterly earnings, beating revenue and EPS estimates, and increased …
Sturm Ruger's recent strong earnings results did not surprise investors, but underlying factors suggest future encouragement for the company. An analysis of the accrual ratio indicates that statutory earnings are less than free cash flow, and the company benefited from unusual items and a …
This article reviews the Ruger EC9s, a sub-compact 9mm pistol, highlighting its surprising trigger quality, comfortable feel, and good concealability despite its small size. The author notes its low price, especially on the used market, but criticizes its abysmal molded sights and the fact …
This article provides a financial overview of Drugs Made In America Acquisition Corp. (DMAAU) as presented on TradingView. It indicates that the market is closed for this stock with no recent trades. The page offers access to financial statements, statistics, dividends, earnings, and segment …
This page provides financial data and an overview for Drugs Made In America Acquisition Corp. (DMAAR) on TradingView. It indicates that the market is closed, with no current trades. Users can find fundamentals, statistics, dividend information, earnings, and segment performance for the company.
This article provides a brief overview of Drugs Made In America Acquisition II Corp. (DMIIU) financial information available on TradingView. It indicates that the market is closed and there are no trades for the company. The page focuses on fundamental data, statements, statistics, dividends, …
Sturm, Ruger & Co. reported strong Q2 2026 results, with net sales of $158.1 million and adjusted diluted EPS of $0.52, exceeding previous year's performance. The company declared a quarterly dividend of $0.21 per share and attributed its success to improved manufacturing, a stronger …
Search by ticker symbol or company name and select a result to open its chart.